Loading...
XSHE
300171
Market cap1.68bUSD
Dec 05, Last price  
15.62CNY
1D
1.49%
1Q
10.08%
Jan 2017
4.90%
IPO
42.78%
Name

Tofflon Science and Technology Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300171 chart
P/E
61.23
P/S
2.37
EPS
0.26
Div Yield, %
1.53%
Shrs. gr., 5y
3.51%
Rev. gr., 5y
17.22%
Revenues
5.01b
-11.19%
167,224,594216,248,562308,065,550480,617,136648,865,071821,857,9441,021,120,6211,258,693,7061,555,556,0691,327,836,6021,724,879,1801,916,821,8922,264,004,3282,707,688,1624,192,421,1075,469,426,3625,641,696,4425,010,142,452
Net income
194m
-67.66%
45,975,21653,385,42675,875,578142,844,836217,402,530233,328,902266,362,878335,411,145386,685,252234,511,455123,097,84270,457,732145,814,757463,493,693827,775,241846,569,056600,237,388194,093,221
CFO
881m
P
32,324,23156,174,914119,108,275118,385,926113,473,861347,375,486338,950,15155,060,521140,664,561107,413,33820,916,734222,035,747446,307,7381,115,814,5391,368,930,358247,153,989-312,382,622880,608,714
Dividend
Jul 12, 20240.23919 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines. The company also provides active pharmaceutical ingredients; and visual inspection, leak detection, and combination systems, as well as focuses on providing bio-process equipment and integrated systems, including medium preparation, cell/microbial cultivation, harvesting, DF/UF, purification, buffer preparation, and finished filling systems. In addition, it offers lyophilization injectable lab services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. The company was founded in 1993 and is headquartered in Shanghai, China.
IPO date
Feb 01, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT